Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Healthstream (HSTM) EBITDA Margin (2016 - 2025)

Historic EBITDA Margin for Healthstream (HSTM) over the last 17 years, with Q3 2025 value amounting to 9.89%.

  • Healthstream's EBITDA Margin rose 10100.0% to 9.89% in Q3 2025 from the same period last year, while for Sep 2025 it was 7.54%, marking a year-over-year increase of 3000.0%. This contributed to the annual value of 8.6% for FY2024, which is 13600.0% up from last year.
  • According to the latest figures from Q3 2025, Healthstream's EBITDA Margin is 9.89%, which was up 10100.0% from 7.91% recorded in Q2 2025.
  • In the past 5 years, Healthstream's EBITDA Margin registered a high of 9.89% during Q3 2025, and its lowest value of 0.71% during Q4 2021.
  • In the last 5 years, Healthstream's EBITDA Margin had a median value of 5.96% in 2025 and averaged 5.64%.
  • As far as peak fluctuations go, Healthstream's EBITDA Margin plummeted by -65700bps in 2021, and later surged by 52000bps in 2022.
  • Healthstream's EBITDA Margin (Quarter) stood at 0.71% in 2021, then soared by 728bps to 4.49% in 2022, then surged by 34bps to 6.03% in 2023, then increased by 5bps to 6.32% in 2024, then skyrocketed by 57bps to 9.89% in 2025.
  • Its EBITDA Margin was 9.89% in Q3 2025, compared to 7.91% in Q2 2025 and 5.96% in Q1 2025.